SG10201500929XA - Methods and apparatus for synthesizing imaging agents, and intermediates thereof - Google Patents
Methods and apparatus for synthesizing imaging agents, and intermediates thereofInfo
- Publication number
- SG10201500929XA SG10201500929XA SG10201500929XA SG10201500929XA SG10201500929XA SG 10201500929X A SG10201500929X A SG 10201500929XA SG 10201500929X A SG10201500929X A SG 10201500929XA SG 10201500929X A SG10201500929X A SG 10201500929XA SG 10201500929X A SG10201500929X A SG 10201500929XA
- Authority
- SG
- Singapore
- Prior art keywords
- intermediates
- methods
- imaging agents
- synthesizing imaging
- synthesizing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C07D237/16—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Cameras In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30247710P | 2010-02-08 | 2010-02-08 | |
| US31537610P | 2010-03-18 | 2010-03-18 | |
| US33369310P | 2010-05-11 | 2010-05-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201500929XA true SG10201500929XA (en) | 2015-04-29 |
Family
ID=44356121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012057279A SG183134A1 (en) | 2010-02-08 | 2011-02-08 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
| SG10201500929XA SG10201500929XA (en) | 2010-02-08 | 2011-02-08 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012057279A SG183134A1 (en) | 2010-02-08 | 2011-02-08 | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
Country Status (20)
| Country | Link |
|---|---|
| US (5) | US8936777B2 (en) |
| EP (3) | EP3323810B1 (en) |
| JP (3) | JP6092628B2 (en) |
| KR (5) | KR101709372B1 (en) |
| CN (3) | CN113058046A (en) |
| AU (3) | AU2011213568B2 (en) |
| BR (1) | BR112012019789A2 (en) |
| CA (1) | CA2789044C (en) |
| DK (2) | DK3323810T3 (en) |
| ES (2) | ES2909318T3 (en) |
| HK (1) | HK1255702A1 (en) |
| IL (2) | IL221253B (en) |
| MX (1) | MX348958B (en) |
| NO (1) | NO2534136T3 (en) |
| NZ (1) | NZ602291A (en) |
| PT (2) | PT2534136T (en) |
| RU (1) | RU2631500C2 (en) |
| SG (2) | SG183134A1 (en) |
| TW (4) | TWI686370B (en) |
| WO (1) | WO2011097649A2 (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| US7485283B2 (en) | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
| EP2474525B1 (en) | 2006-12-26 | 2020-04-15 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
| PT2257315T (en) | 2008-02-29 | 2020-01-27 | Lantheus Medical Imaging Inc | Contrast agents for applications including perfusion imaging |
| PT2419096T (en) | 2009-04-15 | 2020-02-19 | Lantheus Medical Imaging Inc | Stabilization of radiopharmaceutical compositions using ascorbic acid |
| US10109385B2 (en) | 2009-09-23 | 2018-10-23 | Abt Molecular Imaging, Inc. | Dose synthesis card for use with automated biomarker production system |
| PT2534136T (en) * | 2010-02-08 | 2017-12-15 | Lantheus Medical Imaging Inc | Methods for synthesizing imaging agents, and intermediates thereof |
| CA2798488C (en) | 2010-05-11 | 2019-06-04 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| US11129911B2 (en) | 2011-05-05 | 2021-09-28 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| CA2845308C (en) * | 2011-05-05 | 2021-01-26 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| CN104159890B (en) * | 2011-09-09 | 2018-04-10 | 蓝瑟斯医学影像公司 | Composition, method and system for synthesizing and using developer |
| CA2852395C (en) * | 2011-10-21 | 2020-04-28 | Lantheus Medical Imaging, Inc. | Compositions comprising ascorbic acid and pyridaben and pyridaben analogs attached to an imaging moiety and related methods |
| WO2013070471A1 (en) | 2011-11-11 | 2013-05-16 | Lantheus Medical Imaging, Inc. | Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging |
| EP2836241B1 (en) * | 2012-04-10 | 2019-02-20 | Lantheus Medical Imaging, Inc. | Radiopharmaceutical synthesis methods |
| CA2794281C (en) * | 2012-04-30 | 2019-07-02 | Elazar A. Bienenstock | Single photon emission computed tomography imaging method |
| WO2013172979A1 (en) * | 2012-05-14 | 2013-11-21 | University Of Southern California | Methods and compositions for positron emission tomography myocardial perfusion imaging |
| AU2013203000B9 (en) * | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| WO2015021078A1 (en) | 2013-08-05 | 2015-02-12 | Cedars-Sinai Medical Center | Methods for reducing ischemia-reperfusion injury |
| JP6190240B2 (en) | 2013-10-16 | 2017-08-30 | 浜松ホトニクス株式会社 | Diagnostic agent for therapeutic effect on cancer |
| US9031300B1 (en) | 2013-10-25 | 2015-05-12 | General Electric Company | System and method reconstructing a nuclear medicine image using deformed attenuation image |
| CN107530455A (en) * | 2015-02-10 | 2018-01-02 | Abt分子成像公司 | With automatic biological label production system associated with dosage synthesize card |
| NL2014828B1 (en) * | 2015-05-20 | 2017-01-31 | Out And Out Chemistry S P R L | Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method. |
| CN105553594B (en) * | 2015-12-09 | 2018-02-16 | 沈阳东软医疗系统有限公司 | A kind of PET clock synchronizing methods and device |
| US11109819B2 (en) | 2016-04-11 | 2021-09-07 | The General Hospital Corporation | System and method for quantitatively mapping mitochondrial membrane potential |
| JP6060302B1 (en) * | 2016-06-10 | 2017-01-11 | 日本メジフィジックス株式会社 | Method and apparatus for analyzing myocardial nuclear medicine image data |
| TWI649067B (en) * | 2017-03-01 | 2019-02-01 | 醫百科技股份有限公司 | Positioning corrector |
| CN108129673B (en) * | 2017-12-26 | 2020-10-13 | 武汉大学 | Preparation and application of high-sensitivity water-soluble dendritic macromolecule F19 developer |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| CN108658868A (en) * | 2018-05-07 | 2018-10-16 | 四川大学 | A kind of bicarbonate ion liquid and preparation method thereof and a kind of recrystallization method of photoacoustic spectroscopy |
| EP3671511B1 (en) | 2018-12-19 | 2022-07-06 | Rohde & Schwarz GmbH & Co. KG | Communication system and method |
| CN109806822B (en) * | 2019-01-30 | 2021-07-30 | 杭州吉蕊科技有限公司 | Modularized and multifunctional PET probe automatic synthesis system |
| CN109896934A (en) * | 2019-03-08 | 2019-06-18 | 山东省药学科学院 | A kind of preparation method of high-purity 2- benzyloxy bromoethane |
| GB201915206D0 (en) | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
| GB201919016D0 (en) * | 2019-12-20 | 2020-02-05 | Ge Healthcare Ltd | Apparatus and method for solid phase extraction |
| CN111333638A (en) * | 2020-03-17 | 2020-06-26 | 四川大学华西医院 | 18F-labeled isoquinolino pyridazinone compound and synthesis method and application thereof |
| JP7362561B2 (en) * | 2020-07-30 | 2023-10-17 | 富士フイルム株式会社 | Radiographic image processing device, method and program |
| WO2022261502A1 (en) * | 2021-06-11 | 2022-12-15 | Jubilant Draximage Inc. | Non-invasive imaging methods of diagnosing peripheral arterial disease |
| GB202108608D0 (en) | 2021-06-16 | 2021-07-28 | Ge Healthcare Ltd | Preparation of a ph-adjusted ascorbic acid solution |
| GB202108605D0 (en) | 2021-06-16 | 2021-07-28 | Ge Healthcare Uk Ltd | Effect of water content |
| CN114700006B (en) * | 2022-06-07 | 2023-03-24 | 北京先通国际医药科技股份有限公司 | Production equipment of liquid composition and preparation method and application thereof |
| CN114716415B (en) * | 2022-06-09 | 2022-09-02 | 北京先通国际医药科技股份有限公司 | Apparatus for producing liquid composition, method for producing the same and use thereof |
| CN114732918B (en) * | 2022-06-10 | 2022-09-13 | 北京先通国际医药科技股份有限公司 | Production equipment of liquid composition and preparation method and application thereof |
| CN114773179B (en) * | 2022-06-23 | 2022-09-16 | 北京先通国际医药科技股份有限公司 | Preparation method of compound I liquid composition and application of compound I liquid composition in myocardial metabolism PET imaging |
Family Cites Families (126)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1073999A (en) | 1965-01-29 | 1967-06-28 | Ncr Co | Process for forming stable images in photochromic material |
| US4510125A (en) | 1982-12-08 | 1985-04-09 | Mallinckrodt, Inc. | Process for making lyophilized radiographic imaging kit |
| JPS604173A (en) | 1983-06-23 | 1985-01-10 | Nissan Chem Ind Ltd | Pyridazinone derivative, its preparation and insecticidal, miticidal and fungicidal agent |
| DE3574870D1 (en) | 1984-06-23 | 1990-01-25 | Nissan Chemical Ind Ltd | METHOD FOR PRODUCING 2-TERT.-BUTYL-4,5-DICHLORO-3 (2H) -PYRIDAZINONE. |
| JPH07116161B2 (en) | 1984-07-04 | 1995-12-13 | 日産化学工業株式会社 | Pyridazinone derivative |
| JPS61130275A (en) | 1984-11-29 | 1986-06-18 | Nissan Chem Ind Ltd | Pyridazinone derivative, preparation thereof, and insecticidal, miticidal and fungicidal agent |
| DE3578304D1 (en) | 1984-11-29 | 1990-07-26 | Nissan Chemical Ind Ltd | PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND INSECTICIDAL, ACARICIDIC, NEMATICIDIC, FUNGICIDIC COMPOSITIONS. |
| CA1265798A (en) | 1984-12-10 | 1990-02-13 | Motoo Mutsukado | 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it |
| US5393512A (en) | 1985-01-14 | 1995-02-28 | Vanderheyden; Jean-Luc | Stable therapeutic radionuclide compositions and methods for preparation thereof |
| JPH0641454B2 (en) | 1985-02-27 | 1994-06-01 | 日産化学工業株式会社 | Pyridazinone derivative |
| JPS61260018A (en) * | 1985-05-14 | 1986-11-18 | Nissan Chem Ind Ltd | Anti-allergic agent |
| YU134686A (en) | 1985-07-30 | 1988-02-29 | Nissan Chemical Ind Ltd | Process for preparing new derivatives 3-(2h)-pyridazinone |
| JPH0739397B2 (en) | 1985-07-30 | 1995-05-01 | 日産化学工業株式会社 | Pyridazinone derivatives and pest control agents |
| JPH07110815B2 (en) | 1985-11-18 | 1995-11-29 | ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム | Polychelating agent for image and spectral enhancement (and spectral shift) |
| JPS6315974A (en) | 1986-07-09 | 1988-01-23 | 小泉コンピユ−タ−株式会社 | Balling game score table display apparatus |
| US5252317A (en) | 1986-11-10 | 1993-10-12 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Amplifier molecules for diagnosis and therapy derived from 3,5-bis[1-(3-amino-2,2-bis (aminomethyl)-propyl) oxymethyl] benzoic acid |
| US5567411A (en) | 1986-11-10 | 1996-10-22 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group |
| JPS63159372A (en) | 1986-12-24 | 1988-07-02 | Nissan Chem Ind Ltd | Pyridazinone compound and insecticide, acaricide and nematocide |
| JPS63159374A (en) | 1986-12-24 | 1988-07-02 | Nissan Chem Ind Ltd | Pyridazinone derivative and insecticide, acaricide and nematocide |
| JPS63159373A (en) | 1986-12-24 | 1988-07-02 | Nissan Chem Ind Ltd | Pyridazinones and insecticide, acaricide and nematocide |
| DE3824210A1 (en) | 1988-07-16 | 1990-01-18 | Basf Ag | 3 (2H) -PYRIDAZINONE DERIVATIVES FOR CONTROLLING SNAILS |
| IT1229684B (en) | 1989-04-05 | 1991-09-06 | Mini Ricerca Scient Tecnolog | PYRIDAZINONE WITH INSECTICIDE AND ACARICIDE ACTIVITY |
| JPH02279676A (en) | 1989-04-19 | 1990-11-15 | Otsuka Chem Co Ltd | Pyridazinone derivative |
| US5087440A (en) | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
| GB8923843D0 (en) | 1989-10-23 | 1989-12-13 | Salutar Inc | Compounds |
| US5377681A (en) | 1989-11-13 | 1995-01-03 | University Of Florida | Method of diagnosing impaired blood flow |
| US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
| US5228446A (en) | 1989-12-22 | 1993-07-20 | Unger Evan C | Gas filled liposomes and their use as ultrasonic contrast agents |
| US5088499A (en) | 1989-12-22 | 1992-02-18 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| US5679810A (en) | 1990-01-19 | 1997-10-21 | Salutar, Inc. | Linear oligomeric polychelant compounds |
| JPH03220177A (en) | 1990-01-25 | 1991-09-27 | Nissan Chem Ind Ltd | Insecticidal/miticidal agent composition |
| WO1992017215A1 (en) | 1990-03-28 | 1992-10-15 | Nycomed Salutar, Inc. | Contrast media |
| GB9006977D0 (en) | 1990-03-28 | 1990-05-23 | Nycomed As | Compositions |
| JPH04235975A (en) | 1991-01-21 | 1992-08-25 | Nissan Chem Ind Ltd | Pyridazinone drivative and insect pest control agent |
| US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
| US5093105A (en) | 1991-04-09 | 1992-03-03 | Merck Frosst Canada, Inc. | Radiopharmaceutical bacteriostats |
| US5306482A (en) | 1991-04-09 | 1994-04-26 | Merck Frosst Canada, Inc. | Radiopharmaceutical bacteriostats |
| ES2150916T3 (en) | 1991-08-29 | 2000-12-16 | Mallinckrodt Medical Inc | USE OF GENISTIC ACID OR GENTISILIC ALCOHOL TO STABILIZE RADIO-MARKED PEPTIDES AND PROTEINS. |
| US5169942A (en) | 1991-11-21 | 1992-12-08 | General Electric Company | Method for making 2-(18F)fluoro-2-deoxy-D-glucose |
| WO1994012479A1 (en) | 1992-12-03 | 1994-06-09 | Otsuka Kagaku Kabushiki Kaisha | Pyridazinone derivative and insecticidal and miticidal agent |
| US5760191A (en) | 1993-02-05 | 1998-06-02 | Nycomed Imaging As | Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
| WO1994021653A1 (en) | 1993-03-22 | 1994-09-29 | General Electric Company | Method for making 2-fluoro-2-deoxyglucose |
| CA2158249A1 (en) | 1993-03-31 | 1994-10-13 | James W. Brodack | Radiopharmaceutical formulations having non-stannous reductants |
| US5417959A (en) | 1993-10-04 | 1995-05-23 | Mallinckrodt Medical, Inc. | Functionalized aza-crytand ligands for diagnostic imaging applications |
| US5493026A (en) | 1993-10-25 | 1996-02-20 | Organix, Inc. | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders |
| JPH07252236A (en) | 1994-01-28 | 1995-10-03 | Takeda Chem Ind Ltd | Anticancer agent |
| EP0665223A1 (en) | 1994-01-28 | 1995-08-02 | Takeda Chemical Industries, Ltd. | Antitumor agent, novel 3(2H)-pyridazinone derivatives and their preparation |
| AU7312694A (en) | 1994-06-03 | 1996-01-04 | Mallinckrodt Medical, Inc. | Rapidly clearing technetium-99m phosphonate skeletal imaging agents |
| US5520904A (en) | 1995-01-27 | 1996-05-28 | Mallinckrodt Medical, Inc. | Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging |
| EP0727225A3 (en) | 1995-02-14 | 1997-01-15 | Sonus Pharma Inc | Compositions and methods for directed ultrasound imaging |
| US5587491A (en) | 1995-03-15 | 1996-12-24 | Regents Of The University Of Minnesota | Method for the synthesis of bis-tetrahydrofuranyl Annonaceous acetogenins |
| US5801228A (en) | 1995-06-07 | 1998-09-01 | Nycomed Imaging As | Polymeric contrast agents for medical imaging |
| US5811073A (en) | 1995-06-19 | 1998-09-22 | President And Fellows Of Harvard College | Method for radioisotopic detection and localization of inflammation in a host |
| US5827073A (en) | 1995-07-05 | 1998-10-27 | Ludwig Institute For Cancer Research | Photoreactive peptide derivatives |
| US6066309A (en) | 1996-02-02 | 2000-05-23 | Rhomed Incorporated | Post-labeling stabilization of radiolabeled proteins and peptides |
| US5804161A (en) | 1996-05-14 | 1998-09-08 | Nycomed Salutar Inc. | Contrast agents |
| US5846517A (en) | 1996-09-11 | 1998-12-08 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a renal contrast agent and a vasodilator |
| US6565889B2 (en) | 1996-12-02 | 2003-05-20 | The Regents Of The University Of California | Bilayer structure which encapsulates multiple containment units and uses thereof |
| US5961955A (en) | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
| AU5671699A (en) | 1998-08-14 | 2000-03-06 | Smithkline Beecham Corporation | Grp receptor ligands |
| US6056939A (en) | 1998-08-28 | 2000-05-02 | Desreux; Jean F. | Self-assembling heteropolymetallic chelates as imaging agents and radiopharmaceuticals |
| EP1119356B1 (en) | 1998-09-29 | 2009-08-19 | Merck & Co., Inc. | Radiolabeled neurokinin-1 receptor antagonists |
| US6645508B1 (en) | 1999-06-18 | 2003-11-11 | Jivn-Ren Chen | Stable L-ascorbic acid composition |
| WO2001087354A2 (en) | 2000-05-17 | 2001-11-22 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands for diagnostic imaging |
| GB0019357D0 (en) | 2000-08-07 | 2000-09-27 | Melacure Therapeutics Ab | Novel phenyl guanidines |
| WO2002020008A1 (en) | 2000-09-06 | 2002-03-14 | The Scripps Research Institute | Inhibitors of nadh:ubiquinone oxidoreductase |
| TWI247609B (en) | 2001-01-23 | 2006-01-21 | Nihon Mediphysics Co Ltd | Agent for diagnosis of tissue proliferation activity or the treatment of proliferative disease |
| GB0115927D0 (en) | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase nucleophilic fluorination |
| US20030044354A1 (en) | 2001-08-16 | 2003-03-06 | Carpenter Alan P. | Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release |
| US7344702B2 (en) * | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| US20030082191A1 (en) | 2001-08-29 | 2003-05-01 | Poduslo Joseph F. | Treatment for central nervous system disorders |
| US7186241B2 (en) * | 2001-10-03 | 2007-03-06 | Medical Instill Technologies, Inc. | Syringe with needle penetrable and laser resealable stopper |
| JP2005529840A (en) | 2001-10-16 | 2005-10-06 | ヒプニオン， インコーポレイテッド | Treatment of CNS disorders using CNS targeted modulators |
| JP4530665B2 (en) | 2002-02-06 | 2010-08-25 | ジョンズ ホプキンス ユニバーシティ | Non-invasive imaging techniques for mitochondria by using radiolabeled lipophilic salts |
| EA009334B1 (en) | 2002-03-29 | 2007-12-28 | Янссен Фармацевтика Н.В. | Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| AU2003224747A1 (en) | 2002-04-08 | 2003-10-27 | Biostream, Inc. | Technetium-labeled rotenone derivatives, and methods of use thereof |
| GB0229683D0 (en) | 2002-12-20 | 2003-01-29 | Imaging Res Solutions Ltd | Preparation of radiopharmaceuticals |
| CN1984660B (en) | 2003-07-03 | 2010-12-15 | 美瑞德生物工程公司 | 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
| WO2005007632A1 (en) | 2003-07-18 | 2005-01-27 | Pharmacia Corporation | Substituted pyridazinones as inhibitors of p38 |
| CA2783275A1 (en) | 2003-07-24 | 2005-02-03 | Bracco Imaging S.P.A. | Stable radiopharmaceutical compositions and methods for their preparation |
| GB0317920D0 (en) | 2003-07-31 | 2003-09-03 | Amersham Plc | Solid-phase synthesis |
| US7927616B2 (en) | 2004-01-16 | 2011-04-19 | Thomas T. Yamashita | Pesticide compositions and methods for their use |
| AU2005216949B2 (en) * | 2004-02-24 | 2011-09-22 | The General Hospital Corporation | Catalytic radiofluorination |
| WO2005085200A1 (en) | 2004-03-05 | 2005-09-15 | Banyu Pharmaceutical Co., Ltd. | Pyridone derivative |
| AT500838B1 (en) | 2004-04-20 | 2007-11-15 | Veterinaermedizinische Uni Wie | MULTIPLE HSE |
| US7485283B2 (en) | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
| US20060083681A1 (en) | 2004-10-18 | 2006-04-20 | Ajay Purohit | Compounds for myocardial perfusion imaging |
| US7534418B2 (en) | 2004-12-10 | 2009-05-19 | The Regents Of The University Of Michigan | Imaging agents |
| KR100789847B1 (en) | 2004-12-15 | 2007-12-28 | (주)퓨쳐켐 | A Preparation Method of Organo Fluoro Compounds in Alcohol Solvents |
| EP1893244A4 (en) | 2005-06-23 | 2009-06-24 | Univ Emory | Imaging agents |
| US7824659B2 (en) | 2005-08-10 | 2010-11-02 | Lantheus Medical Imaging, Inc. | Methods of making radiolabeled tracers and precursors thereof |
| JP2007112725A (en) * | 2005-10-18 | 2007-05-10 | Inst Nuclear Energy Research Rocaec | Method for producing amino acid o-(2-[18f] fluoroethyl)-l-tyrosine labeled with 18f of non-substrate |
| GB0524851D0 (en) * | 2005-12-06 | 2006-01-11 | Ge Healthcare Ltd | Radiolabelling method using polymers |
| US7871623B2 (en) * | 2005-12-21 | 2011-01-18 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for imaging pain and stress in vivo |
| EP2023919A4 (en) | 2006-05-08 | 2010-12-22 | Molecular Neuroimaging Llc | Compounds and amyloid probes thereof for therapeutic and imaging uses |
| US10328164B2 (en) | 2006-06-21 | 2019-06-25 | Ge Healthcare Limited | Radiopharmaceutical products |
| WO2008022979A1 (en) | 2006-08-25 | 2008-02-28 | Boehringer Ingelheim International Gmbh | New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| WO2009110894A1 (en) * | 2008-03-05 | 2009-09-11 | Rhino Technologies Llc | Tensionable spiral bolt with resin nut and related method |
| GB0625523D0 (en) | 2006-12-21 | 2007-01-31 | Ge Healthcare Ltd | In vivo imaging agents |
| EP2474525B1 (en) | 2006-12-26 | 2020-04-15 | Lantheus Medical Imaging, Inc. | Ligands for imaging cardiac innervation |
| JP5504563B2 (en) | 2006-12-27 | 2014-05-28 | 住友化学株式会社 | Composition and light-emitting device using the composition |
| CA2683433C (en) | 2007-04-05 | 2016-10-11 | Siemens Medical Solutions Usa, Inc. | Nitro-imidazole hypoxia imaging agents |
| GB0718386D0 (en) | 2007-09-21 | 2007-10-31 | Ge Healthcare As | Improved radiopharmaceutical formulation |
| CN101157649A (en) * | 2007-10-23 | 2008-04-09 | 江苏省原子医学研究所 | 18F-Fallypride automatically synthesizing method |
| KR101068835B1 (en) * | 2007-10-26 | 2011-09-30 | 한국과학기술연구원 | Isoindolones with high binding affinity to ?-amyloid aggregates and fibrils, and preparation method thereof |
| CL2008003785A1 (en) | 2007-12-21 | 2009-10-09 | Du Pont | Pyridazine derived compounds; herbicidal compositions comprising said compounds; and method of controlling the growth of unwanted vegetation. |
| WO2009103478A1 (en) | 2008-02-19 | 2009-08-27 | Boehringer Ingelheim International Gmbh | Pyridone and pyridazinone derivatives as mch antagonists |
| WO2010011367A2 (en) | 2008-02-22 | 2010-01-28 | Illinois Institute Of Technology | Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
| PT2257315T (en) * | 2008-02-29 | 2020-01-27 | Lantheus Medical Imaging Inc | Contrast agents for applications including perfusion imaging |
| US8258134B2 (en) | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
| WO2009146388A1 (en) | 2008-05-28 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Voxel-based methods for assessing subjects using positron emission tomography |
| KR20110121632A (en) * | 2009-02-25 | 2011-11-07 | 포컬 테크놀러지스 코퍼레이션 | Low-loss collimators for use in fiber optic rotary joints |
| EP2406233B1 (en) | 2009-03-09 | 2013-11-13 | Bristol-Myers Squibb Company | Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| PT2419096T (en) | 2009-04-15 | 2020-02-19 | Lantheus Medical Imaging Inc | Stabilization of radiopharmaceutical compositions using ascorbic acid |
| CN101555232B (en) | 2009-05-21 | 2011-01-05 | 北京师范大学 | Pyridazinone compound marked by fluorine-18, preparation method and applications |
| KR20120051641A (en) | 2009-07-11 | 2012-05-22 | 바이엘 파마 악티엔게젤샤프트 | Non-polar and polar leaving groups |
| PT2534136T (en) | 2010-02-08 | 2017-12-15 | Lantheus Medical Imaging Inc | Methods for synthesizing imaging agents, and intermediates thereof |
| CA2798488C (en) | 2010-05-11 | 2019-06-04 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| DE102010036356A1 (en) * | 2010-07-12 | 2012-01-12 | Abx Advanced Biochemical Compounds Gmbh | Apparatus for the synthesis of radioactively labeled compounds |
| JP5842594B2 (en) | 2010-12-27 | 2016-01-13 | 住友化学株式会社 | Pyridazinone compounds, herbicides containing them, and harmful arthropod control agents |
| CN102336741B (en) | 2011-07-06 | 2013-04-10 | 北京师范大学 | Fluorine-18-marked myocardial perfusion developing agent and preparation method and application thereof |
| CN104159890B (en) | 2011-09-09 | 2018-04-10 | 蓝瑟斯医学影像公司 | Composition, method and system for synthesizing and using developer |
| CA2852395C (en) | 2011-10-21 | 2020-04-28 | Lantheus Medical Imaging, Inc. | Compositions comprising ascorbic acid and pyridaben and pyridaben analogs attached to an imaging moiety and related methods |
| AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| US20150246143A1 (en) | 2012-08-13 | 2015-09-03 | Lantheus Medical Imaging, Inc. | System and method for quantitative mapping of mitochondrial complex 1 |
| WO2014047446A1 (en) | 2012-09-21 | 2014-03-27 | The General Hospital Corporation | System and method for single-scan rest-stress cardiac pet |
-
2011
- 2011-02-08 PT PT117405464T patent/PT2534136T/en unknown
- 2011-02-08 WO PCT/US2011/024109 patent/WO2011097649A2/en active Application Filing
- 2011-02-08 SG SG2012057279A patent/SG183134A1/en unknown
- 2011-02-08 US US13/577,674 patent/US8936777B2/en active Active
- 2011-02-08 DK DK17189439.7T patent/DK3323810T3/en active
- 2011-02-08 KR KR1020127023380A patent/KR101709372B1/en active IP Right Grant
- 2011-02-08 CN CN202110332645.5A patent/CN113058046A/en active Pending
- 2011-02-08 CN CN201811073733.2A patent/CN109200296B/en active Active
- 2011-02-08 ES ES17189439T patent/ES2909318T3/en active Active
- 2011-02-08 CA CA2789044A patent/CA2789044C/en active Active
- 2011-02-08 MX MX2012009174A patent/MX348958B/en active IP Right Grant
- 2011-02-08 KR KR1020187013968A patent/KR20180055933A/en not_active Application Discontinuation
- 2011-02-08 DK DK11740546.4T patent/DK2534136T3/en active
- 2011-02-08 NZ NZ602291A patent/NZ602291A/en unknown
- 2011-02-08 KR KR1020217035027A patent/KR102438133B1/en active IP Right Grant
- 2011-02-08 EP EP17189439.7A patent/EP3323810B1/en active Active
- 2011-02-08 TW TW107133234A patent/TWI686370B/en active
- 2011-02-08 KR KR1020177004163A patent/KR20170033873A/en not_active Application Discontinuation
- 2011-02-08 KR KR1020197015985A patent/KR20190067255A/en not_active Application Discontinuation
- 2011-02-08 SG SG10201500929XA patent/SG10201500929XA/en unknown
- 2011-02-08 RU RU2012138262A patent/RU2631500C2/en active
- 2011-02-08 TW TW106115472A patent/TWI664169B/en active
- 2011-02-08 BR BR112012019789A patent/BR112012019789A2/en not_active Application Discontinuation
- 2011-02-08 NO NO11740546A patent/NO2534136T3/no unknown
- 2011-02-08 ES ES11740546.4T patent/ES2651466T3/en active Active
- 2011-02-08 CN CN201180016758.9A patent/CN102858752B/en active Active
- 2011-02-08 JP JP2012552155A patent/JP6092628B2/en active Active
- 2011-02-08 EP EP21216335.6A patent/EP4046990A1/en active Pending
- 2011-02-08 EP EP11740546.4A patent/EP2534136B1/en active Active
- 2011-02-08 TW TW105121479A patent/TWI660947B/en active
- 2011-02-08 TW TW100104222A patent/TWI589302B/en active
- 2011-02-08 PT PT171894397T patent/PT3323810T/en unknown
- 2011-02-08 AU AU2011213568A patent/AU2011213568B2/en active Active
-
2012
- 2012-08-01 IL IL221253A patent/IL221253B/en active IP Right Grant
-
2014
- 2014-12-05 US US14/561,594 patent/US9603951B2/en active Active
-
2015
- 2015-09-14 JP JP2015181159A patent/JP6254126B2/en active Active
-
2016
- 2016-08-11 AU AU2016213781A patent/AU2016213781A1/en not_active Abandoned
-
2017
- 2017-02-15 US US15/433,387 patent/US10022462B2/en active Active
- 2017-11-29 JP JP2017229034A patent/JP6685269B2/en active Active
-
2018
- 2018-02-21 US US15/901,286 patent/US10842892B2/en active Active
- 2018-03-16 AU AU2018201916A patent/AU2018201916C1/en active Active
- 2018-11-21 HK HK18114852.8A patent/HK1255702A1/en unknown
- 2018-12-06 IL IL263543A patent/IL263543B/en active IP Right Grant
-
2020
- 2020-10-05 US US17/062,757 patent/US20210187131A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL263543B (en) | Methods and apparatus for synthesizing imaging agents, and intermediates thereof | |
| EP2633678A4 (en) | Cellscope apparatus and methods for imaging | |
| GB2485534B (en) | Imaging recording apparatus | |
| EP2555686A4 (en) | Methods and apparatus for ultrasound imaging | |
| EP2581028A4 (en) | Imaging apparatus for endoscopes | |
| EP2531109A4 (en) | Dental imaging apparatus | |
| EP2544898A4 (en) | Image forming apparatus | |
| GB2481971B (en) | Apparatus & method | |
| EP2605053A4 (en) | Imaging apparatus | |
| EP2548083A4 (en) | Image forming apparatus | |
| EP2571250A4 (en) | Imaging apparatus | |
| EP2596320A4 (en) | Method and apparatus for imaging | |
| EP2587665A4 (en) | Amplifier apparatus | |
| GB201121699D0 (en) | Image forming apparatus | |
| GB201012037D0 (en) | Apparatus & method | |
| EP2747410A4 (en) | Imaging apparatus | |
| GB0804629D0 (en) | Imaging apparatus & method | |
| GB201006180D0 (en) | Imaging apparatus | |
| HK1176691A1 (en) | Imaging apparatus | |
| EP2645404A4 (en) | Exposure apparatus | |
| EP2590024A4 (en) | Imaging apparatus and imaging method | |
| HK1172760A1 (en) | Imaging apparatus | |
| GB201012231D0 (en) | Apparatus & Method | |
| EP2401952A4 (en) | Endoscope apparatus | |
| HK1171139A1 (en) | Imaging apparatus and imaging method |